Cencora ROE 2010-2024 | COR
Cencora ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2024-06-30 | $1.86B | $1.06B | 185.01% |
2024-03-31 | $1.85B | $1.23B | 191.33% |
2023-12-31 | $1.87B | $1.06B | 236.46% |
2023-09-30 | $1.75B | $0.67B | 321.40% |
2023-06-30 | $1.69B | $0.92B | 428.39% |
2023-03-31 | $1.62B | $0.51B | 550.94% |
2022-12-31 | $1.73B | $0.07B | 441.05% |
2022-09-30 | $1.70B | $0.07B | 324.24% |
2022-06-30 | $1.84B | $0.52B | 282.41% |
2022-03-31 | $1.73B | $0.91B | 276.43% |
2021-12-31 | $1.61B | $0.60B | 433.29% |
2021-09-30 | $1.54B | $0.58B | 1633.95% |
2021-06-30 | $-3.74B | $0.41B | 1430.37% |
2021-03-31 | $-3.75B | $-0.10B | -596.42% |
2020-12-31 | $-3.22B | $-0.51B | -203.89% |
2020-09-30 | $-3.41B | $-0.84B | -137.71% |
2020-06-30 | $1.57B | $3.97B | 45.72% |
2020-03-31 | $1.58B | $3.71B | 49.18% |
2019-12-31 | $0.65B | $3.07B | 21.30% |
2019-09-30 | $0.86B | $2.99B | 27.83% |
2019-06-30 | $0.96B | $3.11B | 30.94% |
2019-03-31 | $0.93B | $3.04B | 29.69% |
2018-12-31 | $1.19B | $3.17B | 37.03% |
2018-09-30 | $1.66B | $3.05B | 52.78% |
2018-06-30 | $1.08B | $3.28B | 37.31% |
2018-03-31 | $0.85B | $3.36B | 31.46% |
2017-12-31 | $0.98B | $2.88B | 39.03% |
2017-09-30 | $0.36B | $2.06B | 15.67% |
2017-06-30 | $0.85B | $2.55B | 36.62% |
2017-03-31 | $1.15B | $2.53B | 53.29% |
2016-12-31 | $1.35B | $2.12B | 64.69% |
2016-09-30 | $1.43B | $2.13B | 76.17% |
2016-06-30 | $1.64B | $1.88B | 109.79% |
2016-03-31 | $1.51B | $2.19B | 106.14% |
2015-12-31 | $0.39B | $1.30B | 28.99% |
2015-09-30 | $-0.14B | $0.62B | -9.39% |
2015-06-30 | $-0.43B | $1.58B | -24.00% |
2015-03-31 | $-0.66B | $1.92B | -34.61% |
2014-12-31 | $0.03B | $1.77B | 1.68% |
2014-09-30 | $0.27B | $1.96B | 13.15% |
2014-06-30 | $0.26B | $1.99B | 11.91% |
2014-03-31 | $0.44B | $2.15B | 19.27% |
2013-12-31 | $0.31B | $2.25B | 13.12% |
2013-09-30 | $0.43B | $2.32B | 18.43% |
2013-06-30 | $0.55B | $2.42B | 22.85% |
2013-03-31 | $0.56B | $2.35B | 22.21% |
2012-12-31 | $0.73B | $2.34B | 27.18% |
2012-09-30 | $0.72B | $2.46B | 25.56% |
2012-06-30 | $0.70B | $2.93B | 24.11% |
2012-03-31 | $0.71B | $2.95B | 23.66% |
2011-12-31 | $0.71B | $2.91B | 23.36% |
2011-09-30 | $0.71B | $2.87B | 23.21% |
2011-06-30 | $0.70B | $3.20B | 22.85% |
2011-03-31 | $0.68B | $3.13B | 22.67% |
2010-12-31 | $0.65B | $2.96B | 22.13% |
2010-09-30 | $0.64B | $2.95B | 22.20% |
2010-06-30 | $0.63B | $2.93B | 22.28% |
2010-03-31 | $0.58B | $2.83B | 20.99% |
2009-12-31 | $0.54B | $2.74B | 19.75% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $46.107B | $262.173B |
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $96.890B | 12.02 |
DiDi Global (DIDIY) | China | $23.233B | 0.00 |
ICON (ICLR) | Ireland | $18.679B | 16.64 |
Revvity (RVTY) | United States | $15.535B | 26.63 |
Avantor (AVTR) | United States | $15.498B | 23.24 |
Natera (NTRA) | United States | $15.385B | 0.00 |
Viatris (VTRS) | United States | $13.858B | 4.22 |
BioMerieux (BMXMF) | France | $13.601B | 0.00 |
Solventum (SOLV) | United States | $12.636B | 0.00 |
CochLear (CHEOY) | Australia | $12.565B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
HealthEquity (HQY) | United States | $7.792B | 42.29 |
Doximity (DOCS) | United States | $7.787B | 49.34 |
Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
Life Times (LTH) | United States | $4.762B | 31.52 |
PACS (PACS) | United States | $4.502B | 0.00 |
Sotera Health (SHC) | United States | $4.367B | 23.36 |
Organon (OGN) | United States | $4.239B | 4.28 |
Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
Concentras Parent (CON) | United States | $2.480B | 0.00 |
Premier (PINC) | United States | $2.271B | 11.34 |
GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
Progyny (PGNY) | United States | $1.425B | 25.06 |
Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
CareDx (CDNA) | United States | $1.228B | 0.00 |
Agilon Health (AGL) | United States | $1.123B | 0.00 |
Embecta (EMBC) | United States | $0.864B | 5.76 |
InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
SBC Medicals (SBC) | United States | $0.722B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
Enhabit (EHAB) | United States | $0.382B | 33.04 |
DocGo (DCGO) | United States | $0.355B | 13.35 |
COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
ModivCare (MODV) | United States | $0.232B | 7.37 |
Beauty Health (SKIN) | United States | $0.211B | 0.00 |
Biodesix (BDSX) | United States | $0.195B | 0.00 |
LifeMD (LFMD) | United States | $0.192B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
MultiPlan (MPLN) | United States | $0.136B | 0.00 |
Nutex Health (NUTX) | United States | $0.127B | 0.00 |
So-Young (SY) | China | $0.092B | 22.35 |
Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
OncoCyte (OCX) | United States | $0.049B | 0.00 |
NeueHealth (NEUE) | United States | $0.041B | 1.63 |
Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
Oncology Institute (TOI) | United States | $0.021B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
XWELL (XWEL) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
KindlyMD (KDLY) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |